ES2019163A6 - Procedimiento para preparar derivados de imidazol. - Google Patents

Procedimiento para preparar derivados de imidazol.

Info

Publication number
ES2019163A6
ES2019163A6 ES8903313A ES8903313A ES2019163A6 ES 2019163 A6 ES2019163 A6 ES 2019163A6 ES 8903313 A ES8903313 A ES 8903313A ES 8903313 A ES8903313 A ES 8903313A ES 2019163 A6 ES2019163 A6 ES 2019163A6
Authority
ES
Spain
Prior art keywords
optionally substituted
hydrogen atom
image
halogen atoms
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES8903313A
Other languages
English (en)
Inventor
Nigel S Watson
Chuen Chan
Barry C Ross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888823192A external-priority patent/GB8823192D0/en
Priority claimed from GB888823191A external-priority patent/GB8823191D0/en
Priority claimed from GB898902847A external-priority patent/GB8902847D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ES2019163A6 publication Critical patent/ES2019163A6/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR DERIVADOS DE IMIDAZOL DE FORMULA FORMULA DONDE UNO DE RBS1 Y RBS2 REPRESENTA ALQUILO CSI1-6 Y EL OTRO REPRESENTA FENILO O PIRIDILO, RBS3 ES FENILO O PIRIDILO, X ES -CH = CH- Y Z ES FORMULA DONDE RBS4 ES HIDROGENO, UN PROTECTOR DE CARBOXILO O UN CATION Y RBS5 ES HIDROGENO O ALQUILO CSI1-3. CONSISTE EN REDUCIR UN COMPUESTO DE FORMULA FORMULA DONDE RBS1-RBS4 Y X SON COMO ANTES, CON UN AGENTE REDUCTOR APROPIADO TAL COMO HIDRURO METALICO, PARTICULARMENTE BOROHIDRURO DE SODIO, EN UN DISOLVENTE PROTICO TAL COMO UN ALCOHOL, ESPECIALMENTE METANOL O ETANOL, Y EN PRESENCIA DE UN CODISOLVENTE TAL COMO UN ETER, PARTICULARMENTE TETRAHIDROFURANO. HAY ADEMAS OTRAS VIAS DE SINTESIS QUE SE EXPLICAN EN LA MEMORIA. LOS COMPUESTOS OBTENIDOS SON UTILES EN MEDICINA POR SU ACTIVIDAD HIPOCOLESTEROLEMICA E HIPOLIPIDEMICA.
ES8903313A 1988-10-03 1989-10-02 Procedimiento para preparar derivados de imidazol. Expired - Fee Related ES2019163A6 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB888823192A GB8823192D0 (en) 1988-10-03 1988-10-03 Chemical compounds
GB888823191A GB8823191D0 (en) 1988-10-03 1988-10-03 Chemical compounds
GB898902847A GB8902847D0 (en) 1989-02-09 1989-02-09 Chemical compounds

Publications (1)

Publication Number Publication Date
ES2019163A6 true ES2019163A6 (es) 1991-06-01

Family

ID=27264106

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8903313A Expired - Fee Related ES2019163A6 (es) 1988-10-03 1989-10-02 Procedimiento para preparar derivados de imidazol.

Country Status (19)

Country Link
US (2) US5013749A (es)
JP (1) JPH02188571A (es)
KR (1) KR900006297A (es)
AU (1) AU628862B2 (es)
BE (1) BE1003007A3 (es)
CH (1) CH680442A5 (es)
DE (1) DE3932887A1 (es)
DK (1) DK483689A (es)
ES (1) ES2019163A6 (es)
FI (1) FI894648A (es)
FR (1) FR2637183A1 (es)
GB (1) GB2223224B (es)
GR (1) GR890100634A (es)
IT (1) IT1237470B (es)
LU (1) LU87600A1 (es)
NL (1) NL8902441A (es)
NO (1) NO893909L (es)
PT (1) PT91878B (es)
SE (1) SE8903226L (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3913725A1 (de) * 1989-04-26 1990-10-31 Basf Ag 1-halogenvinyl-azole und diese enthaltende fungizide und wachstumsregulatoren
CA2027179A1 (en) * 1989-10-10 1991-04-11 Barry C. Ross Chemical compounds
SK4112003A3 (en) * 2000-10-12 2004-01-08 Nissan Chemical Ind Ltd Preventives and remedies for complications of diabetes
MXPA03009850A (es) * 2001-04-27 2004-02-12 Bristol Myers Squibb Co Inhibidores de bisarilimidazolil de hidrolasa de amida del acido graso.
MXPA06011657A (es) * 2004-04-16 2007-04-23 Warner Lambert Co Nuevos imidazoles.
US7199126B2 (en) * 2004-04-29 2007-04-03 Pharmix Corporation Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
EP1755607A2 (en) * 2004-04-29 2007-02-28 Pharmix Corporation Compositions and treatments for inhibiting kinase and/or hmg-coa reductase
US20050282883A1 (en) * 2004-04-29 2005-12-22 John Griffin Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US7163945B2 (en) * 2004-04-29 2007-01-16 Pharmix Corp. Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US20060084695A1 (en) * 2004-04-29 2006-04-20 John Griffin Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US20050272770A1 (en) * 2004-04-29 2005-12-08 John Griffin Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US7183285B2 (en) * 2004-04-29 2007-02-27 Pharmix Corp. Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US20060111436A1 (en) * 2004-11-23 2006-05-25 John Griffin Compositions and treatments for modulating kinase and/or HMG-CoA reductase
US8372877B2 (en) 2010-04-16 2013-02-12 Cumberland Pharmaceuticals Stabilized statin formulations
EP2626069A4 (en) 2010-10-06 2014-03-19 Univ Tokyo A MEDICINAL PRODUCT FOR THE PREVENTION AND TREATMENT OF A DERY LYMPH

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
US4647576A (en) * 1984-09-24 1987-03-03 Warner-Lambert Company Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
US4668794A (en) * 1985-05-22 1987-05-26 Sandoz Pharm. Corp. Intermediate imidazole acrolein analogs
HUT48208A (en) * 1985-10-25 1989-05-29 Sandoz Ag Process for producing heterocyclic analogues of mevalolactone derivatives and pharmaceutical compositions comprising such compounds
EP0244364A3 (en) * 1986-04-30 1992-04-01 Sandoz Ag Preparation of olefinic compounds
DE3800785A1 (de) * 1988-01-09 1989-07-20 Hoechst Ag Substituierte 7-(pyridazin-5-yl)-3,5-dihydroxyheptan(en)- saeuren, ihre entsprechenden (delta)-lactone bzw. derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte
NO890522L (no) * 1988-02-25 1989-08-28 Bayer Ag Substituerte imidazolinoner og imidazolinthioner.

Also Published As

Publication number Publication date
SE8903226L (sv) 1990-04-04
DK483689A (da) 1990-04-04
FI894648A0 (fi) 1989-10-02
IT8948424A0 (it) 1989-10-02
PT91878B (pt) 1995-05-31
CH680442A5 (es) 1992-08-31
IT1237470B (it) 1993-06-07
LU87600A1 (fr) 1990-05-15
NO893909L (no) 1990-04-04
PT91878A (pt) 1990-04-30
NL8902441A (nl) 1990-05-01
AU4243189A (en) 1990-04-05
GB8922212D0 (en) 1989-11-15
GB2223224A (en) 1990-04-04
AU628862B2 (en) 1992-09-24
GB2223224B (en) 1992-01-08
DK483689D0 (da) 1989-10-02
KR900006297A (ko) 1990-05-07
FR2637183A1 (fr) 1990-04-06
GR890100634A (el) 1990-11-29
JPH02188571A (ja) 1990-07-24
FI894648A (fi) 1990-04-04
US5013749A (en) 1991-05-07
NO893909D0 (no) 1989-10-02
US5120848A (en) 1992-06-09
SE8903226D0 (sv) 1989-10-02
BE1003007A3 (fr) 1991-10-22
DE3932887A1 (de) 1990-04-05

Similar Documents

Publication Publication Date Title
ES8405782A1 (es) Un procedimiento para la produccion de un derivado de carbostirilo.
ES473074A1 (es) Un procedimiento para la preparacion de derivados de tieno- tiacina
ES2019163A6 (es) Procedimiento para preparar derivados de imidazol.
TW369526B (en) Diazabicyclic neurokinin antagonists
MY131297A (en) Herbicides
ES8106721A1 (es) Un metodo para la preparacion de derivados de ftalimidina
IL68075A0 (en) Pyridine and pyrane derivatives,their preparation and pharmaceutical compositions containing them
IL104024A (en) 4-pyrimidinyl and pyridinyl derivatives of indol-3-yl- alkyl piperazines and antimigraine pharmaceutical compositions containing them
ES8406440A1 (es) Procedimiento para preparar derivados de 2-amino-3-acilamino-6-bencilamino-piridina
EP0353955A3 (en) Novel compounds
IL57577A (en) 1,2-dihydroquinolin-2-one derivatives,processes for their preparation and pharmaceutical compositions containing the same
IL108259A0 (en) Piperazine derivates, their preparation and pharmaceutical compositions containing them
FI882590A0 (fi) Analogiamenetelmä lääkeaineena käytettävän pyridiinijohdannaisen valmistamiseksi
ES8300769A1 (es) Un procedimiento para la preparacion de derivados del acido penen-3-carboxilico.
MY103502A (en) Novel compounds
ES8702433A1 (es) Un procedimiento para la preparacion de un compuesto heterociclico sustituido con peptidos.
ES8203867A1 (es) Procedimiento para la obtencion de derivados de benzotiazol
HUP9903526A2 (hu) Pirimidinszármazékok és az ezeket tartalmazó gyógyszerkészítmények
ES8202818A1 (es) Un procedimiento para preparar derivados de tetrazolilcuma- rina
IE780778L (en) 3-pyridazinones.
YU165791A (sh) Postupak za pripremanje derivata 8-hlorohinolona
ES8203870A1 (es) Procedimiento para preparar difenilbutil-1-acilpiperazinas
ZA854005B (en) Penem derivatives
IE820238L (en) Carbapenem derivatives
IL115085A (en) Piperazine bicyclic carboxamide derivatives their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2009-10-02

FD1A Patent lapsed

Effective date: 20010201